Antonio Maraver was born in Madrid in 1973. He has been working in international prestigious research centers all over the world as: CNB (Madrid, Spain), The Scripps Research Institute (San Diego, USA), Turku University (Turku, Finland), The Skirball Institute of Biomolecular Medicine, NYU (New York, USA) and CNIO (Madrid, Spain). Since January 2015 he is group leader of the "Oncogenic pathways in lung cancer" laboratory at IRCM (Montpellier, France).